Aduro Biotech In Shares Up 28.7% Since SmarTrend's Buy Recommendation (ADRO)

SmarTrend identified an Uptrend for Aduro Biotech In (NASDAQ:ADRO) on June 9th, 2017 at $10.73. In approximately 2 months, Aduro Biotech In has returned 28.67% as of today's recent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.